Despite the low potency of ω-Avsp1a, its selectivity for CaV3.1/CaV3.3 over CaV3.2 makes it a useful pharmacological tool for dissecting out the role of these different CaV3 subtypes in disorders such as epilepsy or pain. This evidence concerns the gene CACNA1I and epilepsy.